Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae

LUIS MARTINEZ MARTINEZ2026-01-292026-01-29202110.1128/AAC.00900-212-s2.0-85112792092https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33812Infectious DiseasesPharmacologyPharmacology (medical)Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniaeresearch article